Sign in

HLYK on OTC

HealthLynked Corp

HealthLynked Corp is an American Offices and Clinics of Doctors of Medicine services company.1 It is headquartered in Naples, Florida.1 Its shares trade on OTC under the symbol HLYK.1

Price unavailable

Last updated Oct 21, 2026.

Overview

Compare with Basel Medical Group Ltd, Cardiff Lexington Corp or Concord Medical Services Holdings Ltd, or pick any stock.

  • TickerHLYK on OTC1
  • IndustryServices-Offices & Clinics of Doctors of Medicine1
  • HeadquartersNaples, Florida1
  • Incorporated inNV2
  • Business address1265 Creekside Parkway, Suite 302, Naples, Fl 341082
  • Filer categoryNon-accelerated filer, Smaller reporting company2

See how the biggest companies compare on our leaderboards

AI-enabled features), on-demand telemedicine services, and concierge support, delivering a technology-enabled patient experience.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2025

-102.3%Operating margin4
-158.8%Net margin4
-31.3%Revenue growth, 20254

What sells

Revenue by product, business segment and region, as the company reports it to the SEC.

Products and services

Patent Service Revenue Net brought in 48% of the revenue HealthLynked Corp broke down this way in fiscal 2025.

  1. Patent Service Revenue Net$2.0M448%down 30% from 2024
  2. Patient Service Revenue Net$2.0M448%down 30% from 2024
  3. Product And Other Revenue$40.1K41%down 61% from 2024
  4. Product Revenue$40.1K41%down 61% from 2024
  5. Subscription And Event Revenue$22.6K41%down 30% from 2024
  6. Subscription Revenue$22.6K41%down 30% from 2024
Products and services by year
Products and services20242025
Patent Service Revenue Net$2.9M$2.0M
Patient Service Revenue Net$2.9M$2.0M
Product And Other Revenue$103.8K$40.1K
Product Revenue$103.8K$40.1K
Subscription And Event Revenue$32.4K$22.6K
Subscription Revenue$32.4K$22.6K

Business segments

Health Services brought in 97% of the revenue HealthLynked Corp broke down this way in fiscal 2025.

  1. Health Services$2.0M497%down 30% from 2024
  2. Medical Distribution$40.1K42%down 61% from 2024
  3. Digital Healthcare$22.6K41%down 30% from 2024
Business segments by year
Business segments20242025
Health Services$2.9M$2.0M
Medical Distribution$103.8K$40.1K
Digital Healthcare$32.4K$22.6K

Where the money goes

Where each dollar of revenue went, fiscal 2025

  • Selling, general and admin99¢$2.0M
  • Other costs1¢$29.8K

Out of $2.1M in revenue.4 The company lost money this year.

Financial statements

Revenue567894$2.1M in 2025−49% since 2019
0$2.0M$4.0M$6.0M$8.0M2019: $4.0M$4.0M20192020: $6.1M$6.1M2020+53%2021: $6.5M$6.5M2021+6%2022: $5.9M$5.9M2022−10%2023: $5.7M$5.7M2023−2%2024: $3.0M$3.0M2024−47%2025: $2.1M$2.1M2025−31%
Operating income567894-$2.1M in 2025−34% since 2019
-$10.0M-$7.5M-$5.0M-$2.5M02019: -$3.2M-$3.2M20192020: -$3.1M-$3.1M2020−4%2021: -$5.3M-$5.3M2021+74%2022: -$8.7M-$8.7M2022+62%2023: -$4.2M-$4.2M2023−52%2024: -$4.7M-$4.7M2024+13%2025: -$2.1M-$2.1M2025−55%
Net income567894-$3.3M in 2025−41% since 2019
-$15.0M-$10.0M-$5.0M02019: -$5.5M-$5.5M20192020: -$5.8M-$5.8M2020+4%2021: -$10.4M-$10.4M2021+81%2022: -$8.8M-$8.8M2022−15%2023: -$1.0M-$1.0M2023−89%2024: -$6.1M-$6.1M2024+506%2025: -$3.3M-$3.3M2025−47%

Every line of the income statement as filed: the last 2 fiscal years, latest first.4

Period ending2025-12-312024-12-31
Total revenue$2.1M$3.0M
Practice salaries and benefits$1.0M$2.0M
Other practice operating expenses$973.0K$1.6M
Cost of product revenue$51.6K$96.2K
Selling, general and administrative expenses$2.0M$3.0M
Depreciation and amortization$101.9K$282.9K
Impairment loss$716.0K
Total Operating Expenses and Costs$4.2M$7.7M
Loss from operations-$2.1M-$4.7M
Gain (loss) on extinguishment of debt$318.0K-$179.0K
Gain (loss) on change in fair value of debt-$618.2K$84.1K
Gain on sale of assets$168.7K
Gain on change in fair value of derivative financial instruments$8.6K
Amortization of original issue discounts on notes payable-$828.0K-$1.3M
Gain from realization of contingent sale consideration receivable$125.4K
Interest expense and other-$216.1K-$168.1K
Total other income (expenses)-$1.2M-$1.5M
Loss before provision for income taxes-$3.3M-$6.1M
Net loss-$3.3M-$6.1M
Basic (in Dollars per share)-$1.16-$2.18
Fully diluted (in Dollars per share)-$1.16-$2.18
Basic (in Shares)2.8M shares2.8M shares
Fully diluted (in Shares)2.8M shares2.8M shares

Compare HealthLynked Corp with another company

What it owns

What HealthLynked Corp reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.

Property and equipment

ItemLatestA year beforeChange
Property and equipment, before depreciation$803.4K4 Dec 31, 2025$811.4K4 Dec 31, 2024−1.0%
Accumulated depreciation$728.7K4 Dec 31, 2025$634.8K4 Dec 31, 2024+14.8%
Property and equipment, net$74.7K4 Dec 31, 2025$176.6K4 Dec 31, 2024−57.7%
Operating-lease assets (leased space)$76.1K4 Dec 31, 2025$361.1K4 Dec 31, 2024−78.9%

Investments

ItemLatestA year beforeChange
Cash and cash equivalents$37.1K4 Dec 31, 2025$76.2K9 Dec 31, 2024−51.3%

Intangibles and goodwill

ItemLatestA year beforeChange
Accumulated amortization$09 Dec 31, 2024$258.7K9 Dec 31, 2023−100.0%

Inventory

ItemLatestA year beforeChange
Inventory, total$18.0K4 Dec 31, 2025$44.7K4 Dec 31, 2024−59.8%

Properties, in its own words

The Company leases its operating facilities pursuant to a lease agreement for approximately 3,650 square feet that commenced in August 2023 and expires in July 2026, located in Naples, FL.

Item 2 of the 10-K filed Mar 31, 2026.3

Leadership

Who has led HealthLynked Corp, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Michael T. Dent2018–now

Chief financial officer

  1. David Rosal2024
  2. Jeremy Daniel2025

Chief operating officer

  1. William Crupi2024
20202025
Board members and other officers (6)

Timeline

  1. Jul 16, 20268-K Executive or director change21
  2. Feb 6, 20268-K Entered a material agreement; New debt or obligation; Unregistered sale of shares22
  3. Dec 12, 20258-K Executive or director change; Regulation FD disclosure23
  4. Sep 5, 20258-K Change to shareholders' rights; Bylaws or fiscal year changed; Regulation FD disclosure24
  5. Mar 26, 20258-K Entered a material agreement; New debt or obligation; Unregistered sale of shares25
  6. Feb 4, 20258-K Other events26
  7. Jan 15, 20258-K Executive or director change; Regulation FD disclosure27
  8. Sep 24, 20248-K Entered a material agreement; New debt or obligation; Unregistered sale of shares28
  9. Jun 26, 20248-K Executive or director change; Regulation FD disclosure29
  10. Jun 5, 20248-K Entered a material agreement; New debt or obligation; Unregistered sale of shares30
  11. Mar 14, 20248-K Executive or director change31
  12. Jan 11, 20248-K Executive or director change32
  13. Feb 16, 2018New chief executive Michael T. Dent becomes CEO12

Filings

99 filings to the SEC since October 2021: 6 annual reports, 15 quarterly reports, 21 major events, 41 insider forms, 16 other. The latest 20:

  1. Aug 14, 202610-Q QUARTERLY REPORT EDGAR
  2. Jul 24, 20264 EDGAR
  3. Jul 16, 20268-K CURRENT REPORT EDGAR
  4. May 29, 2026S-1/A AMENDMENT NO. 2 TO FORM S-1 EDGAR
  5. May 15, 202610-Q QUARTERLY REPORT EDGAR
  6. Apr 30, 2026S-1/A AMENDMENT NO. 1 TO FORM S-1 EDGAR
  7. Mar 31, 202610-K ANNUAL REPORT EDGAR
  8. Feb 10, 2026S-1 REGISTRATION STATEMENT EDGAR
  9. Feb 6, 20268-K CURRENT REPORT EDGAR
  10. Jan 9, 2026DRS EDGAR
  11. Dec 12, 20258-K CURRENT REPORT EDGAR
  12. Nov 19, 202510-Q QUARTERLY REPORT EDGAR
  13. Nov 17, 2025NT 10-Q NOTIFICATION OF LATE FILING EDGAR
  14. Sep 5, 20258-K CURRENT REPORT EDGAR
  15. Aug 14, 202510-Q QUARTERLY REPORT EDGAR
  16. May 15, 202510-Q QUARTERLY REPORT EDGAR
  17. Apr 30, 20251-A EDGAR
  18. Apr 18, 20254 EDGAR
  19. Apr 10, 20254 EDGAR
  20. Mar 31, 20254 EDGAR

The 99 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

2 open-market trades by officers, directors and large owners since October 2021: 2 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Jun 24, 2024Rosal DavidChief Financial OfficerBuy28,333$0.08$2.3KForm 4
Jun 20, 2024Rosal DavidChief Financial OfficerBuy33,667$0.08$2.7KForm 4

From Forms 4 filed with the SEC.

Held by these funds

The largest holders among investment managers' 13F reports for the quarter ending Jun 30, 2026. Change is in shares since the quarter before.

FundSharesValueShare of the fundChange
Ancora Advisors LLC74$2220.0%No change

13F reports cover disclosed long positions in U.S. stocks only.

SEC filer profile

How HealthLynked Corp is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.

  • Name on EDGARHealthLynked Corp1
  • CIK0001680139
  • Employer ID (EIN)47-16341273
  • Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company3
  • Incorporated inNevada3
  • Fiscal year endsDecember 311
  • Industry code (SIC)8011 Services-Offices & Clinics of Doctors of Medicine1
  • SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
  • Business address1265 Creekside Parkway, Suite 302, Naples, FL 341081
  • Phone800-928-71441
  • Shares outstanding2,953,225 as of Aug 14, 202611
  • Public float$3.8M as of Jun 30, 20253
  • AuditorRBSM LLP, Houston, TX PCAOB ID 587; no auditor attestation of internal control over financial reporting3
  • On EDGAR sinceJul 22, 20161
  • Filings224 in all: 8-K (54), 4 (51), 10-Q (29), 3 (10), 10-K (9), CORRESP (9), EFFECT (9), UPLOAD (8)1
    All 25 form types

    POS AM (6), S-1 (5), S-1/A (5), 4/A (4), D (4), 8-K/A (3), DEF 14C (3), 10-K/A (2), 424B3 (2), DRS (2), PRE 14C (2), S-8 (2), 1-A (1), 424B5 (1), 8-A12G (1), NT 10-Q (1), S-3 (1)

  • Latest filingsAnnual report (10-K) Mar 31, 2026
    Quarterly report (10-Q) Aug 14, 2026
    Latest 8-K (8-K) Jul 16, 2026

Risk factors and legal proceedings

The risks HealthLynked Corp names in Item 1A of its 10-K filed Mar 31, 2026: 32 risks under these headings, as written.3

  • FINANCIAL AND GENERAL BUSINESS RISKS
  • There is substantial doubt about our ability to continue as a going concern and a failure to obtain financing could prevent us from executing our business plan or operate as a going concern.
  • Our substantial indebtedness, including convertible related-party debt, could adversely affect our business, financial condition, and results of operations.
  • Our future success depends on our ability to execute our business plan by fully developing the HealthLynked Network and recruiting physicians and patients to adopt and use the system. However, there is no guarantee that we will be able to successfully implement our business plan.
  • Failure to remediate a material weakness in internal accounting controls could result in material misstatements in our financial statements.
  • We may not be able to effectively control and manage our growth.
  • The departure or loss of Dr. Michael Dent could disrupt our business.
  • Our sales strategy may not be successful.
  • Key components of our product sales made through MOD are provided by a sole supplier, and supply shortages or loss of this supplier could result in interruptions in supply or increased costs.
  • The healthcare industry is highly regulated, and government authorities may determine that we have failed to comply with applicable laws, rules, or regulations.
  • We rely on Amazon Web Services, or AWS, for the vast majority of our computing, storage, bandwidth, and other services. Any disruption of or interference with our use of the platform would negatively affect our operations and seriously harm our business.
  • Federal and state laws that protect the privacy and security of protected health information may increase our costs and limit our ability to collect and use that information and subject us to penalties if we are unable to fully comply with such laws.
The other 21 risks
  • RISKS RELATED TO THE HEALTHLYNKED NETWORK
  • The market for Internet-based personal medical information and record archiving systems may not develop substantially further or develop more slowly than we expect, harming the growth of our business.
  • If we do not continue to innovate and provide services that are useful to our target users, we may not remain competitive, and our revenues and operating results could suffer.
  • We may be unable to adequately protect, and we may incur significant costs in enforcing, our intellectual property and other proprietary rights.
  • We may be sued by third parties for alleged infringement of their proprietary rights.
  • We may not be able to properly safeguard the information on the HealthLynked Network.
  • Our employees may not take all appropriate measures to secure and protect confidential information in their possession.
  • RISKS RELATED TO THE PROVISION OF MEDICAL SERVICES
  • We may not be able to successfully recruit and retain qualified physicians, who are key to our Health Services segment’s revenues and billing.
  • We may be subject to medical malpractice and other lawsuits not covered by insurance.
  • Certain federal and state laws may limit our effectiveness at collecting monies owed to us from patients.
  • We may not be able to maintain effective and efficient information systems.
  • RISKS RELATING TO OUR ORGANIZATION
  • Our articles of incorporation authorize our Board to create new series of preferred stock without further approval by our stockholders, which could adversely affect the rights of the holders of our common stock.
  • Stockholders’ ability to influence corporate decisions may be limited because Michael Dent, our Chief Executive Officer and Chairman of the Board, currently owns a controlling percentage of the voting power of our common stock.
  • If we fail to establish and maintain an effective system of internal control, we may not be able to report our financial results accurately or to prevent fraud. Any inability to report and file our financial results accurately and timely could harm our reputation and adversely impact the trading price of our common stock.
  • Our stockholders are subject to significant dilution upon the occurrence of certain events which could result in a decrease in our stock price.
  • The public market for our common stock is limited, which could negatively affect its value and make it difficult or impossible for you to sell your shares.
  • We may not be able to maintain a listing of our common stock on Nasdaq.
  • We do not intend to pay dividends for the foreseeable future.
  • Our issuance of additional common stock or preferred stock may cause our common stock price to decline, which may negatively impact your investment.
  • Anti-takeover provisions in our charter and bylaws may prevent or frustrate attempts by stockholders to change the Board of Directors or current management and could make a third-party acquisition of us difficult.
  • Our common stock is subject to the “penny stock” rules of the SEC and the trading market in the securities is limited, which makes transactions in our common stock cumbersome and may reduce the value of an investment in our common stock.
  • We are a “smaller reporting company”, and we cannot be certain if the reduced reporting requirements applicable to smaller reporting companies will make our common stock less attractive to investors.

Legal proceedings

From time to time, we may become involved in various lawsuits and legal proceedings, which arise, in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are not aware of any such legal proceedings that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results.

The opening of Item 3, Legal Proceedings.3

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
    SEC EDGAROther events
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32